This marks the FIRST antigen rapid test to be approved by Taiwan FDA for the detection of SARS-CoV-2 (COVID-19 virus). Vstrip® will continue to apply for approval from other international regulatory agencies including U.S. FDA (EUA), EU CE certification, and Japan PMDA.
